| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $23.4M | -54.1% |
| R&D Expense | $129.5M | +44.6% |
| SG&A Expense | $28.3M | +18.5% |
| Operating Income | -$134.4M | -115.1% |
| Income Tax | $0 | — |
| Net Income | -$113.0M | -92.6% |
| EPS (Basic) | -$1.96 | -38.0% |
| EPS (Diluted) | -$1.96 | -38.0% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $157.0M | +128.8% |
| Short-term Investments | $368.1M | +24.3% |
| Accounts Receivable | $18K | -91.5% |
| Current Assets | $532.6M | +43.8% |
| Total Assets | $649.3M | +67.4% |
| Current Liabilities | $27.1M | -14.6% |
| Total Liabilities | $28.2M | -26.7% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$115.2M | -32.2% |
| Capital Expenditures | $2.4M | -31.2% |
| Investing Cash Flow | -$158.5M | -374.4% |
| Financing Cash Flow | $362.7M | +273.3% |
| Free Cash Flow | -$117.6M | -29.8% |
| Stockholders' Equity |
| $621.1M |
| +77.7% |